Thus, enhanced BM output of IL-27R-sufficient cells upon Ang II treatment drives augmented atherosclerosis, whereas Ang II is unable to cause the same enhancement of atherosclerosis in IL-27R-deficient hosts (Supplementary Fig. 8d). The gene discussed is IL27RA; the disease is atherosclerosis.